// App-Quantinova.ai

OA0014 : Effects of long‐term prophylaxis with subcutaneous C1 inhibitor in special patient populations: Findings from the COMPACT open‐label extension trial

Researchers

Presenter

  • Levy DS

Principal Investigators

  • Craig T

  • Longhurst H

  • Cicardi M

  • Chiao J

  • Feuersenger H

  • Prusty S

  • Pragst I

Medical Centers

  • University of California Irvine,Irvine, United States

  • Department of Medicine, Pediatrics and Graduate Studies, Hershey, United States

  • Addenbrookes Hospital, Cambridge, United Kingdom

  • Kings College London, London, United Kingdom

  • Department of Biochemical and Clinical Science "L. Sacco" - University of Milan, ASST Fatebenefratelli Sacco, Milan, Italy

  • CSL Behring LLC, King of Prussia, Pennsylvania, United States

  • CSL Behring, Marburg, Germany

Locations

  • United States

  • United Kingdom

  • Italy

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved